Stockreport

Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF NEW HAVEN, Conn., November 25, 2024 BUSINESS WIRE )--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into tr [Read more]